Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu
    [{"orgOrder":0,"company":"Fareva","sponsor":"CureVac","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"CureVac and Fareva Sign Agreement for Filling and Packaging of CureVac COVID19 Vaccine Candidate","therapeuticArea":"Infections and Infectious Diseases","highestDevelopmentStatus":"Phase II","country":"LUXEMBOURG","productType":"Vaccine","productStatus":"New Molecular Entity","date":"December 2020","url1":"","url2":"","graph1":"Infections and Infectious Diseases","graph2":"Phase II"}]

    Find Clinical Drug Pipeline Developments & Deals by Fareva

    Menu

    Fareva

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    SERVICES

    Key Services KEY SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Loading...

    All Data

    Previous
    Next
    Filters Filter
    ×
    FILTER:
    filter Company
      filter Sponsor
        filter Country
          filter Therapeutic Area
            filter Study Phase

              Active Filter(s):

              refreshFilters
              refreshReset Filter
              refresh Reset Filter
              price-trend All Developments

              Companies By Therapeutic Area

              Development Status

              Fareva

              Contact Supplier
              • Deals
              Virtual BoothFareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.
              Contact Supplier Contact Supplier
              Flag Luxembourg
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              CureVac and Fareva Sign Agreement for Filling and Packaging of CureVac COVID19 Vaccine Candidate

              Details:

              Under the agreement, Fareva will fill & finish manufacturing of CureVac´s COVID-19 vaccine candidate, CVnCoV, a COVID-19 vaccine candidate developed by CureVac, in France.

              Lead Product(s): CVnCoV

              Therapeutic Area: Infections and Infectious Diseases Product Name: CVnCoV

              Highest Development Status: Phase II Product Type: Vaccine

              Partner/Sponsor/Collaborator: CureVac

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Agreement December 08, 2020

              Fareva Company Banner

              CPhI North America

              Exhibiting

              envelop Contact Supplier

              Fareva
              Send me more info on How To Grow My Business Digitally?
              Post Enquiry
              POST ENQUIRY